Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Oblique Therapeutics AB (publ)

Closing information (x1000 NOK)

Closing information 2023/12 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 61 More Arrow 1,924 Less Arrow 273
Earnings before taxes -62,736 More Arrow -50,651 Less Arrow -60,113
EBITDA -38,257 Less Arrow -45,622 Less Arrow -56,804
Total assets 18,803 Less Arrow 17,193 More Arrow 30,072
Current assets 16,380 Less Arrow 7,669 More Arrow 21,747
Current liabilities 6,202 More Arrow 10,652 Less Arrow 9,317
Equity capital 11,740 Less Arrow 3,181 More Arrow 19,238
- share capital 1,850 Less Arrow 718 More Arrow 740
Employees (average) 18 Equal arrow 18 Less Arrow 16

Financial ratios

Fiscal year 2023/12 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 62.4% Less Arrow 18.5% More Arrow 64.0%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -333.3% More Arrow -283.4% More Arrow -199.0%
Current ratio 264.1% Less Arrow 72.0% More Arrow 233.4%
Return on equity (ROE) -534.4% Less Arrow -1592.3% More Arrow -312.5%
Change turnover
Change turnover % -100%
Chg. No. of employees
Chg. No. of employees % 13% More Arrow 33%

Total value of public sale

Fiscal year 2023/12 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.